Neuronetics (NASDAQ:STIM) is a medical technology company focused on developing innovative therapies for psychiatric and neurological disorders, with a particular emphasis on major depressive disorder. Their cornerstone project revolves around the NeuroStar Advanced Therapy system, a non-invasive treatment which utilizes transcranial magnetic stimulation (TMS) to target key areas of the brain associated with mood regulation. This technology offers hope to patients who haven't responded well to traditional antidepressant medications. With a mission to transform lives by offering new avenues in neurohealth, Neuronetics is dedicated to advancing their research and making their treatments more accessible to those in need. Their objectives include expanding the clinical applications of their technology, increasing adoption by healthcare providers, and continuing to build evidence for the efficacy and safety of their treatments.